TABLE 1 .
Treatment | Cytokine levela (pg/ml) (avg ±SD) |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
IFN-γ | IL-1β | IL-4 | IL-6 | IL-10 | IL-12 | MCP-1 | TGF-β | TNF-α | VEGF | |
Untreated | 1,951.74±16.62 | 791.80±11.57 | 81.25±10.74 | 452.93±8.91 | 398.26±6.61 | 367.91±6.45 | 374.08±11.13 | 1,996.55±5.02 | 3,852.01±15.12 | 4,623.52±15.09 |
MRSA | 2,339.10±10.65ϕ | 859.25±6.47ϕ | 91.52±5.32 | 614.37±4.63ϕ | 321.83±7.36* | 414.53±5.37ϕ | 421.54±4.02ϕ | 2,459.32±4.46ϕ | 4,157.19±8.12ϕ | 2,071.90±23.61* |
METH | 1,398.46±5.68*# | 645.32±6.04*# | 75.26±5.97 | 897.25±7.98ϕχ | 497.21±6.54ϕχ | 362.83±8.81# | 200.87±9.09*# | 2,085.31±16.25# | 2,736.14±11.95*# | 3,027.11±6.72*χ |
METH-MRSA | 1,765.44±4.21*#π | 701.33±9.26*#π | 79.69±5.97 | 811.85±8.23ϕχ& | 505.21±9.22ϕχ | 388.24±8.65# | 398.08±7.12#π | 2,369.84±6.35ϕ | 1,977.25±12.81χ#& | 2,545.15±7.01*χπ |
ϕ, χ, and π indicate a significantly higher cytokine level (P < 0.05) than in the untreated, MRSA, or METH group, respectively. *, #, and & indicate a significantly lower cytokine level (P < 0.05) than in the untreated, MRSA, or METH group, respectively.